Jan Tavernier

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Top Venues

Cancer immunology research

EMBO molecular medicine

Nature structural & molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Stijn De Munter, Juliane L Buhl, Laurenz De Cock, Alexander Van Parys, Willem Daneels, Eva Pascal, Lucas Deseins, Joline Ingels, Glenn Goetgeluk, Hanne Jansen, Lore Billiet, Melissa Pille, Julie Van Duyse, Sarah Bonte, Niels Vandamme, Jo Van Dorpe, Fritz Offner, Georges Leclerq, Tom Taghon, Erik Depla, Jan Tavernier, Tessa Kerre, Jarno Drost, Bart Vandekerckhove
Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced Exhaustion. Cancer immunology research 12 (9) (2024)
Stijn De Munter, Juliane L Buhl, Laurenz De Cock, Alexander Van Parys, Willem Daneels, Eva Pascal, Lucas Deseins, Joline Ingels, Glenn Goetgeluk, Hanne Jansen, Lore Billiet, Melissa Pille, Julie Van Duyse, Sarah Bonte, Niels Vandamme, Jo Van Dorpe, Fritz Offner, Georges Leclerq, Tom Taghon, Erik Depla, Jan Tavernier, Tessa Kerre, Jarno Drost, Bart Vandekerckhove
Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen-induced exhaustion. Cancer immunology research (2024)
Alexandra Tsirigotaki, Ann Dansercoer, Koen H G Verschueren, Iva Marković, Christoph Pollmann, Maximillian Hafer, Jan Felix, Catherine Birck, Wouter Van Putte, Dominiek Catteeuw, Jan Tavernier, J Fernando Bazan, Jacob Piehler, Savvas N Savvides, Kenneth Verstraete
Mechanism of receptor assembly via the pleiotropic adipokine Leptin. Nature structural & molecular biology (2023)
Bram Van Den Eeckhout, Leander Huyghe, Sandra Van Lint, Elianne Burg, Stéphane Plaisance, Frank Peelman, Anje Cauwels, Gilles Uzé, Niko Kley, Sarah Gerlo, Jan Tavernier
Selective IL-1 activity on CD8 + T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication. Journal for immunotherapy of cancer 9 (11) (2022)
Mannon Duquenne, Cintia Folgueira, Cyril Bourouh, Marion Millet, Anisia Silva, Jérôme Clasadonte, Monica Imbernon, Daniela Fernandois, Ines Martinez-Corral, Soumya Kusumakshi, Emilie Caron, Sowmyalakshmi Rasika, Eleonora Deliglia, Nathalie Jouy, Atsuro Oishi, Massimilliano Mazzone, Eric Trinquet, Jan Tavernier, Young-Bum Kim, Stéphane Ory, Ralf Jockers, Markus Schwaninger, Ulrich Boehm, Ruben Nogueiras, Jean-Sébastien Annicotte, Stephane Gasman, Julie Dam, Vincent Prevot
Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function. Nature metabolism 3 (8) (2021)
Nicolas Rosa, Hristina Ivanova, Larry E Wagner, Justin Kale, Rita La Rovere, Kirsten Welkenhuyzen, Nikolaos N Louros, Spyridoula Karamanou, Victoria Shabardina, Irma Lemmens, Elien Vandermarliere, Kozo Hamada, Hideaki Ando, Frederic Rousseau, Joost Schymkowitz, Jan Tavernier, Katsuhiko Mikoshiba, Anastassios Economou, David W Andrews, Jan B Parys, David I Yule, Geert Bultynck
Bcl-xL acts as an inhibitor of IP3R channels, thereby antagonizing Ca2+-driven apoptosis. Cell death and differentiation (2021)
Leander Huyghe, Alexander Van Parys, Anje Cauwels, Sandra Van Lint, Stijn De Munter, Jennyfer Bultinck, Lennart Zabeau, Jeroen Hostens, An Goethals, Nele Vanderroost, Annick Verhee, Gilles Uzé, Niko Kley, Frank Peelman, Bart Vandekerckhove, Peter Brouckaert, Jan Tavernier
Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies. EMBO molecular medicine 12 (2) (2020)
Bram Van Den Eeckhout, Lien Van Hoecke, Elianne Burg, Sandra Van Lint, Frank Peelman, Niko Kley, Gilles Uzé, Xavier Saelens, Jan Tavernier, Sarah Gerlo
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant. NPJ vaccines 5 (1) (2020)